UBI Pharma Inc (ROCO:6562)
NT$ 13.85 -0.1 (-0.72%) Market Cap: 1.64 Bil Enterprise Value: 1.76 Bil PE Ratio: 1,385.00 PB Ratio: 1.40 GF Score: 51/100

UBI Pharma Inc (ROCO:6562) Transcripts

    • 1